Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study.

Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study.

OBJECTIVE: Mitotane treatment in adrenocortical carcinoma (ACC) results in unreliable measurement of serum total cortisol (TC) levels because of an elevation in corticosteroid-binding globulin (CBG). DESIGN: The use of a newly-developed serum-free cortisol (FC) assay was assessed to investigate the...

Full description

Bibliographic Details
Main Authors:	Alexandraki, K, Kaltsas, G, le Roux, C, Fassnacht, M, Ajodha, S, Christ-Crain, M, Akker, SA, Drake, WM, Edwards, R, Allolio, B, Grossman, AB
Format:	Journal article
Language:	English
Published:	2010

Similar Items

SERUM CORTISOL IS NOT AN ACCURATE PREDICTOR OF THE INTEGRITY OF THE HYPOTHALAMIC-PITUITARY-ADRENOCORTICAL AXIS - REPLY
by: Grossman, A
Published: (1995)

Adrenocortical carcinoma: the range of appearances on CT and MRI.
by: Bharwani, N, et al.
Published: (2011)

Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement.
by: Chortis, V, et al.
Published: (2013)

Measurement of serum free cortisol shows discordant responsivity to stress and dynamic evaluation.
by: Christ-Crain, M, et al.
Published: (2007)

Is urinary free cortisol of value in the diagnosis of Cushing's syndrome?
by: Alexandraki, K, et al.
Published: (2011)

Nicotinamide Nucleotide Transhydrogenase as a novel treatment target in adrenocortical carcinoma
by: Chortis, Vasileios, et al.
Published: (2018)

The relationship between cortisol production rate and serial serum cortisol estimation in patients on medical therapy for Cushing's syndrome.
by: Trainer, P, et al.
Published: (1993)

Case report: A giant hemorrhagic adrenocortical carcinoma causing cardiorespiratory embarrassment
by: Yeap, Boon Tat, et al.
Published: (2021)

Everolimus therapy for progressive adrenocortical cancer
by: Fraenkel, M, et al.
Published: (2013)

Everolimus therapy for progressive adrenocortical cancer.
by: Fraenkel, M, et al.
Published: (2013)

Cushing's syndrome with low levels of serum cortisol: the role of inhaled steroids.
by: Matos, A, et al.
Published: (2011)

The prevalence and characteristic features of cyclicity and variability in Cushing's disease.
by: Alexandraki, K, et al.
Published: (2009)

Association of adult height and leg length with fasting plasma cortisol concentrations: evidence for an effect of normal variation in adrenocortical activity on growth.
by: Phillips, D, et al.
Published: (2008)

Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia.
by: Christ-Crain, M, et al.
Published: (2007)

ALTERED ADRENOCORTICAL-RESPONSE TO CRF STIMULATION IN OBESITY
by: Kopelman, P, et al.
Published: (1987)

Effect of adrenergic antagonism on the growth hormone, prolactin and cortisol response to a synthetic opioid agonist in man.
by: Bouloux, P, et al.
Published: (1986)

Lack of modulation of the adrenocortical response to ACTH by an opioid peptide.
by: Howlett, T, et al.
Published: (1991)

Childhood adrenocortical carcinoma as a sentinel cancer for detecting families with germline TP53 mutations
by: Choong, S.S., et al.
Published: (2012)

A common polymorphism in the retinoic acid pathway modifies adrenocortical carcinoma age-dependent incidence
by: Surakhy, M, et al.
Published: (2020)

Adrenocortical Cancer: A Therapeutic Approach with Everolimus (RAD001)
by: Gueorguiev, M, et al.
Published: (2010)

Deconvolution of Serum Cortisol Levels by Using Compressed Sensing
by: Dahleh, Munther A., et al.
Published: (2014)

Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment.
by: Trainer, P, et al.
Published: (1993)

BENZODIAZEPINES ATTENUATE THE SERUM CORTISOL RESPONSE TO CORTICOTROPIN-RELEASING HORMONE (CRH) IN HEALTHY-VOLUNTEERS
by: Trainer, P, et al.
Published: (1992)

Primary pigmented nodular adrenocortical disease
by: Ngow, Harris Abdullah, et al.
Published: (2011)

Adrenocortical function in active and treated tuberculosis in chest clinic Ipoh Hospital
by: A.Muthukumaru, Umadevi
Published: (2002)

An update on adrenocortical cell lines of human origin
by: Sigala, Sandra, et al.
Published: (2022)

Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study.
by: Alexandraki, K, et al.
Published: (2013)

Primary pigmented nodular adrenocortical dysplasia: a rare form of a rare disorder.
by: Jabbar, A, et al.
Published: (1994)

Serum fasting cortisol in relation to bone, and the role of genetic variations in the glucocorticoid receptor.
by: van Schoor, N, et al.
Published: (2007)

BLUNTED CORTISOL RESPONSE TO CRF IN OBESITY
by: Kopelman, P, et al.
Published: (1987)

Diagnosing and treating cortisol insufficiency in ICU
by: Mat Nor, Mohd Basri
Published: (2013)

Serum cortisol measurement in comparison between dexmedetomidine and fentanyl for sympathetic attenuacion during intubation.
by: Yip Kin, Soon
Published: (2011)

Clinical review: Diagnosis and management of pituitary carcinomas.
by: Kaltsas, G, et al.
Published: (2005)

The prognostic role of CD8+ T lymphocytes in childhood adrenocortical carcinomas compared to Ki-67, PD-1, PD-L1, and the Weiss score
by: Parise, IZS, et al.
Published: (2019)

Morbidity in patients on long-term steroid replacement therapy.
by: Druce, MR, et al.
Published: (2010)

Deconvolution analysis of 24-h serum cortisol profiles informs the amount and distribution of hydrocortisone replacement therapy.
by: Peters, C, et al.
Published: (2013)

Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
by: Charmandari, E, et al.
Published: (2001)

The effects of a met-enkephalin analogue on ACTH, beta-LPH, beta-endorphin and MET-enkephalin in patients with adrenocortical disease.
by: Gaillard, R, et al.
Published: (1981)

The cortisol response to corticotrophin-releasing factor is blunted in obesity.
by: Kopelman, P, et al.
Published: (1988)

Endocrine manifestations in Langerhans cell histiocytosis.
by: Makras, P, et al.
Published: (2007)